Quote:When I heard the news about leronlimab and ICIs in TNBC, way back when,
my first thought was--why not just scrap mCRC and get straight into a breast cancer trial?
the big cancers where CCR5 plays an outside role are TNBC, mCRC, prostate and pancreatic cancer. This info is pointed up in a slide from a recent Hoffman presentation that validates the company's focus.
Hopefully this link brings you right to the slide .